Pacific Biosciences of California, Inc. Financing Cash Flow
Pacific Biosciences of California, Inc. (PACB) reported Financing Cash Flow of $1.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $255.00K.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.44M, a 26.65% decline year-over-year.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $1.47M, a 80.91% increase year-over-year.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $3.43M.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$42.99M, a 139.48% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $108.89M, a 1031.69% increase from fiscal 2022.
- Pacific Biosciences of California, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $9.62M, a 99.18% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.69M 10-Q · filed 2026-08-06 | $1.69M derived: sum of 3 quarters · filed 2026-08-06 | $3.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.44M 10-Q · filed 2026-05-08 | $1.44M derived: sum of 2 quarters · filed 2026-05-08 | $2.91M derived: sum of 3 quarters · filed 2026-05-08 | $2.91M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.47M derived: sum of 2 quarters · filed 2026-02-25 | $1.47M derived: sum of 3 quarters · filed 2026-08-06 | $3.43M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.47M derived: sum of 2 quarters · filed 2026-08-06 | $3.43M 10-Q · filed 2025-11-06 | -$46.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.96M 10-Q · filed 2026-08-06 | -$48.24M derived: sum of 3 quarters · filed 2026-08-06 | -$47.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.96M 10-Q · filed 2026-05-08 | -$48.24M derived: sum of 2 quarters · filed 2026-05-08 | -$47.43M derived: sum of 3 quarters · filed 2026-05-08 | -$47.58M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$50.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$49.39M derived: sum of 2 quarters · filed 2026-02-25 | -$49.54M derived: sum of 3 quarters · filed 2026-02-25 | -$42.99M 10-K · filed 2026-02-25 |
| 2024-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $660.00K derived: sum of 2 quarters · filed 2025-11-06 | $7.21M 10-Q · filed 2025-11-06 | -$74.39M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$152.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $6.40M 10-Q · filed 2025-08-07 | -$75.20M derived: sum of 3 quarters · filed 2026-02-25 | -$75.98M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $6.55M 10-Q · filed 2025-05-12 | -$75.05M derived: sum of 2 quarters · filed 2026-02-25 | -$75.83M derived: sum of 3 quarters · filed 2026-02-25 | -$80.55M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$81.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$82.38M derived: sum of 2 quarters · filed 2026-02-25 | -$87.10M derived: sum of 3 quarters · filed 2026-02-25 | $108.89M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$781.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$5.50M derived: sum of 2 quarters · filed 2024-11-12 | $190.49M 10-Q · filed 2024-11-12 | $191.31M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$4.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $191.27M 10-Q · filed 2024-08-09 | $192.09M derived: sum of 3 quarters · filed 2025-03-17 | $195.23M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $195.99M 10-Q · filed 2024-05-09 | $196.81M derived: sum of 2 quarters · filed 2025-03-17 | $199.94M derived: sum of 3 quarters · filed 2025-03-17 | $200.40M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.95M derived: sum of 2 quarters · filed 2025-03-17 | $4.41M derived: sum of 3 quarters · filed 2025-03-17 | $9.62M 10-K · filed 2025-03-17 |
| 2022-09-30 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.59M derived: sum of 2 quarters · filed 2023-11-03 | $8.80M 10-Q · filed 2023-11-03 | $10.13M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $455.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $5.67M 10-Q · filed 2023-08-04 | $6.99M derived: sum of 3 quarters · filed 2024-02-28 | $306.65M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.21M 10-Q · filed 2023-05-04 | $6.54M derived: sum of 2 quarters · filed 2024-02-28 | $306.19M derived: sum of 3 quarters · filed 2024-02-28 | $309.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $300.98M derived: sum of 2 quarters · filed 2024-02-28 | $303.86M derived: sum of 3 quarters · filed 2024-02-28 | $1.17B 10-K · filed 2024-02-28 |
| 2021-09-30 | $299.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $302.54M derived: sum of 2 quarters · filed 2022-11-08 | $1.17B 10-Q · filed 2022-11-08 | $1.29B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $868.60M 10-Q · filed 2022-08-08 | $994.48M derived: sum of 3 quarters · filed 2023-02-28 | $1.10B derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $865.72M 10-Q · filed 2022-05-06 | $991.60M derived: sum of 2 quarters · filed 2023-02-28 | $1.10B derived: sum of 3 quarters · filed 2023-02-28 | $1.10B derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $125.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $233.01M derived: sum of 2 quarters · filed 2023-02-28 | $233.64M derived: sum of 3 quarters · filed 2023-02-28 | $251.84M 10-K · filed 2023-02-28 |
| 2020-09-30 | $107.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $107.76M derived: sum of 2 quarters · filed 2021-11-05 | $125.96M 10-Q · filed 2021-11-05 | $144.09M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $18.83M 10-Q · filed 2021-08-06 | $36.96M derived: sum of 3 quarters · filed 2022-02-28 | $37.28M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $18.20M 10-Q · filed 2021-05-06 | $36.33M derived: sum of 2 quarters · filed 2022-02-28 | $36.66M derived: sum of 3 quarters · filed 2022-02-28 | $38.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $18.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $18.46M derived: sum of 2 quarters · filed 2022-02-28 | $19.86M derived: sum of 3 quarters · filed 2022-02-28 | $26.55M 10-K · filed 2022-02-28 |
| 2019-09-30 | $327.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $1.73M derived: sum of 2 quarters · filed 2020-11-03 | $8.42M 10-Q · filed 2020-11-03 | $13.70M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $8.09M 10-Q · filed 2020-08-06 | $13.37M derived: sum of 3 quarters · filed 2021-02-26 | $79.89M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $6.69M 10-Q · filed 2020-05-08 | $11.97M derived: sum of 2 quarters · filed 2021-02-26 | $78.49M derived: sum of 3 quarters · filed 2021-02-26 | $78.40M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $71.80M derived: sum of 2 quarters · filed 2021-02-26 | $71.71M derived: sum of 3 quarters · filed 2021-02-26 | $107.18M 10-K · filed 2021-02-26 |
| 2018-09-30 | $66.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $66.43M derived: sum of 2 quarters · filed 2019-11-07 | $101.90M 10-Q · filed 2019-11-07 | $102.00M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $35.38M 10-Q · filed 2019-08-06 | $35.48M derived: sum of 3 quarters · filed 2020-02-28 | $37.88M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $35.47M 10-Q · filed 2019-05-03 | $35.57M derived: sum of 2 quarters · filed 2020-02-28 | $37.98M derived: sum of 3 quarters · filed 2020-02-28 | $100.87M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.50M derived: sum of 2 quarters · filed 2020-02-28 | $65.40M derived: sum of 3 quarters · filed 2020-02-28 | $68.81M 10-K · filed 2020-02-28 |
| 2017-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $65.31M derived: sum of 2 quarters · filed 2018-11-05 | $68.71M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $62.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $66.31M 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $3.41M 10-Q · filed 2018-05-02 | |||
| 2016-12-31 | $65.93M 10-K · filed 2019-02-26 | |||
| 2014-03-31 | $22.96M 10-Q · filed 2014-05-08 | $23.28M derived: sum of 2 quarters · filed 2014-05-08 | $24.73M derived: sum of 3 quarters · filed 2014-05-08 | $36.07M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.77M derived: sum of 2 quarters · filed 2014-03-14 | $13.12M derived: sum of 3 quarters · filed 2014-03-14 | $42.77M 10-K · filed 2014-03-14 |
| 2013-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $12.79M derived: sum of 2 quarters · filed 2013-11-12 | $42.45M 10-Q · filed 2013-11-12 | $42.45M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-06-30 | $11.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $41.00M 10-Q · filed 2013-08-09 | $41.01M derived: sum of 3 quarters · filed 2014-05-08 | $41.69M derived: sum of 4 quarters · filed 2014-05-08 |
| 2013-03-31 | $29.66M 10-Q · filed 2014-05-08 | $29.66M derived: sum of 2 quarters · filed 2014-05-08 | $30.34M derived: sum of 3 quarters · filed 2014-05-08 | $30.61M derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $685.00K derived: sum of 2 quarters · filed 2014-03-14 | $950.00K derived: sum of 3 quarters · filed 2014-03-14 | $2.71M 10-K · filed 2014-03-14 |
| 2012-09-30 | $683.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $948.00K derived: sum of 2 quarters · filed 2013-11-12 | $2.70M 10-Q · filed 2013-11-12 | $2.96M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.02M 10-Q · filed 2013-08-09 | $2.28M derived: sum of 3 quarters · filed 2014-03-14 | $6.11M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $1.75M 10-Q · filed 2013-05-10 | $2.01M derived: sum of 2 quarters · filed 2014-03-14 | $5.85M derived: sum of 3 quarters · filed 2014-03-14 | $9.16M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $4.09M derived: sum of 2 quarters · filed 2014-03-14 | $7.41M derived: sum of 3 quarters · filed 2014-03-14 | $7.74M 10-K · filed 2014-03-14 |
| 2011-09-30 | $3.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $7.15M derived: sum of 2 quarters · filed 2012-11-01 | $7.49M 10-Q · filed 2012-11-01 | $218.98M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $3.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $3.65M 10-Q · filed 2012-08-07 | $215.14M derived: sum of 3 quarters · filed 2013-03-15 | $223.58M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $333.00K 10-Q · filed 2012-05-07 | $211.82M derived: sum of 2 quarters · filed 2013-03-15 | $220.26M derived: sum of 3 quarters · filed 2013-03-15 | |
| 2010-12-31 | $211.49M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $219.93M derived: sum of 2 quarters · filed 2013-03-15 | $318.66M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $8.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $107.17M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $98.73M 10-Q · filed 2011-08-12 | |||
| 2009-12-31 | $67.01M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |